Moderna to supply Japan with additional 70 million doses of COVID-19 booster vaccine
On Mar. 16, 2022, Moderna announced an agreement with the Ministry of Health, Labour and Welfare of Japan…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA | Veterinary
USDA confirmed highly pathogenic Avian influenza non-commercial backyard fock in Nebraska
On Mar. 16, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
Pfizer and BioNTech submitted for U.S. EUA of additional booster dose of COVID-19 vaccine for older adults
On Mar. 15, 2022, Pfizer and BioNTech announced the companies had submitted an application to the U.S. Food…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA | Veterinary
USDA confirmed highly pathogenic Avian influenza in Wisconsin
On Mar. 14, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection (APHIS) Service confirmed…
Moderna announced first participant dosed in phase 2 study of Omicron-specific bivalent booster candidate
On Mar. 10, 2022, Moderna announced that the first participant had been dosed in the Phase 2 study…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA
USDA confirmed highly pathogenic Avian influenza in Kansas and Illinois
On Mar. 10, 2022, the Illinois Department of Agriculture (IDOA), in conjunction with the Illinois Department of Natural…
Cocrystal Pharma initiated enrollment in phase 1 influenza a study with novel, broad-spectrum, orally administrated antiviral CC-42344
On Mar. 10, 2022, Cocrystal Pharma announced dosing of the first subjects in a Phase 1 clinical trial…
City of Hope COVID-19 vaccine showed effectiveness in phase 1 trial
On Mar. 10, 2022, the City of Hope announced that its COVID-19 investigational vaccine licensed to GeoVax Labs…
Pfizer initiated phase 2/3 study of novel COVID-19 oral treatment in pediatric participants
On Mar. 9, 2022, Pfizer announced that it had initiated a Phase 2/3 study, EPIC-PEDS (Evaluation of ProteaseInhibition…
Moderna announced MOU with Government of Kenya to establish first mRNA manufacturing facility on the continent of Africa
On Mar. 7, 2022, Moderna announced that with the assistance of the U.S. Government, it had entered into…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA | Veterinary
USDA confirmed highlypathogenic Avian influenza in flock of commercial broiler chickens in Missouri
On Mar. 4, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
Agriculture | Biotechnology | Diagnostics | Disease | Infectious Disease | Influenza | Life Science News | Therapeutics | Vaccine
USDA confirmed highly pathogenic Avian influenza in two backyard flocks in Connecticut and Iowa
On Mar. 2, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) confirmed the…
Sorrento announced FDA authorization to proceed with phase 1 study of Intranasal STI-9199 against Covid-19 viruses
On Mar. 2, 2022, Sorrento Therapeutics announced that it had received clearance from the FDA for its investigational…
Sorrento announced COVISHIELD antibody nasal drops prevent productive SARS-CoV-2 infections
On Mar. 2, 2022, Sorrento Therapeutics announced that new preclinical results demonstrated that pretreating an animal with intranasal…
Oregon Department of Agriculture confirmed highly pathogenic avian influenza in the Pacific Flyway
On Mar. 2, 2022, the World Organization for Animal Health confirmed a bald eagle found dead in British…
Agriculture | Biotechnology | CRISPR | Genomics | Life Science News | USDA
Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and Canola
On Mar. 1, 2022, Yield10 Bioscience announced that 2021 field test results showed that the trait C3020 tested…
U.S. patent appeal board ruled against University of California in CRISPR interference
On Feb. 28, 2022, the Patent and Trial Appeal Board of the U.S. Patent and Trademark Office (USPTO)…
EMA’s Committee for Medicinal Products for Human Use recommended authorization of Covid-19 vaccine in children (6-11 Years) In the EU
On Feb. 24, 2022, Moderna announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA | Veterinary
USDA confirmed highly pathogenic Avian influenza in a non-commercial backyard flock in Michigan
On Feb. 24, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
Medicago and GSK announced approval by Health Canada of COVIFENZ, an adjuvanted plant-based COVID-19 vaccine
On Feb. 24, 2022, Medicago and GlaxoSmithKline announced that Health Canada had granted approval for COVIFENZ, COVID-19 vaccine,…
Novavax announced extended durability of protection against infection and disease in UK COVID-19 vaccine phase 3 clinical Trial
On Feb. 24, 2022, Novavax shared extended analysis from its pivotal Phase 3 clinical trial conducted in the…
Moderna and Thermo Fisher Scientific announced long-term strategic collaboration
On Feb. 23, 2022, Moderna and Thermo Fisher Scientific announced a 15-year strategic collaboration agreement to enable dedicated…
Novavax announced shipments of COVID-19 vaccine to European Union member states
On Feb. 23, 2022, Novavax announced the first doses of Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) had begun shipping…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA | Veterinary
USDA confirmed highly pathogenic Avian influenza in a commercial poultry flock in Delaware
On Feb. 23, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
Sorrento announced COVISHIELD antibody strongly neutralized BA.2 Omicron sublineage virus
On Feb. 22, 2022, Sorrento Therapeutics announced that additional preclinical results demonstrate broad spectrum COVISHIELD (STI-9167) neutralizing activity…
Moderna expanded global footprint through commercial partnership with Adium in Latin America
On Feb. 22, 2022, Moderna announced a distribution service agreement with Adium Pharma, a leading private Latin American…
Blood test for Alzheimer’s highly accurate in large, international study
On Feb. 22, 2022, Washington University in St. Louis announced that a blood test developed at the University’s…
Novavax and Serum Institute of India announced first EUA of COVID-19 vaccine in adolescents =12 to <18 in India
On Mar. 22, 2022, Novavax and Serum Institute of India announced that the Drugs Controller General of India…
The University of Virginia Cancer Center Received NCI Comprehensive Designation
On Feb. 1, 2022, University of Virginia Cancer Center announced it had been awarded a Comprehensive Cancer Center…
Agriculture | Biotechnology | Infectious Disease | Influenza | Life Science News | USDA | Veterinary
USDA confirmed highly pathogenic avian influenza in non-commercial backyard flock in New York
On Feb. 19, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…